Saturday, July 22, 2017

Abilify is the Most Commonly Prescribed Antipsychotic Drug Among Newly Diagnosed Bipolar Disorder Patients in the …

October 23, 2014 by  
Filed under Depression

BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ -- Decision Resources Group finds that, through analysis of U.S. Although multiple generic antipsychotics are now available, Abilify's favorably perceived tolerability profile and its regulatory approval for multiple stages of the illness drive its use in bipolar disorder over that of other atypical antipsychotics. Patient share for Lamotrigine in ...

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!